Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidity

Arthritis and Rheumatism

Volumn 50, Issue 6, 2004, Pages 1734-1739

  Boers, Maarten ^a   Dijkmans, Ben ^a   Gabriel, Sherine ^b   Maradit Kremers, Hilal ^b   O'Dell, James ^c   Pincus, Theodore ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; CORTICOSTEROID; ESTROGEN; METHOTREXATE; NEUROLEPTIC AGENT;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; DISEASE MARKER; DISEASE SEVERITY; HUMAN; INCIDENCE; MORTALITY; NOTE; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS;

EID: 2642527933     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20306     Document Type: Note

References (59)

1. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
2. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-81.
3. Guedes C, Dumont-Fischer D, Leichter-Nakache S, Boissier MC. Mortality in rheumatoid arthritis. Rev Rhum Engl Ed 1999;66: 492-8.
4. Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously: predictive markers, socioeconomic status and comorbidity. J Rheumatol 1986;13:841-5.
5. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
6. Yelin E, Meenan R, Nevitt M, Epstein W. Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med 1980;93:551-6.
7. Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984;43:8-17.
8. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358: 903-11.
9. O'Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 2002;46:283-5.
10. Molenaar E, van der Heijde D, Boers M. Update on outcome assessment in rheumatic disorders. Curr Opin Rheumatol 2000; 12:91-8.
11. Kroot EJ, van Leeuwen MA, van Rijswijk MH, Prevoo ML, van 't Hof MA, van de Putte LB, et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-8.
12. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58: 11-4.
13. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21.
14. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48: 1530-42.
15. Coste J, Jougla E. Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol 1994;23:545-52.
16. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529-33.
17. Landewe RB, van den Borne BE, Breedveld FC, Dijkmans BA. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 2000;355:1616-7.
18. Ward MM. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 2001;44:1467-9.
19. Pincus T, Sokka T, Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum 2001;44: 1234-6.
20. Landewe RB, Breedveld FC, Dijkmans BA. Methotrexate treatment and mortality in rheumatoid arthritis [letter]. Lancet 2002; 360:1095-6.
21. Navarro-Cano G, del Rincon I, Pogosian S, Roldan JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum 2003;48: 2425-33.
22. Callahan LF, Pincus T, Huston JW III, Brooks RH, Nance EP Jr, Kaye JJ. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997;10:381-94.
23. Sherer Y, Shoenfeld Y. Atherosclerosis. Ann Rheum Dis 2002;61: 97-9.
24. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
25. Bergstrom U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L, Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999;28:160-5.
26. Sokka TM, Kaarela K, Mottonen TT, Hannonen PJ. Conventional monotherapy compared with a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol 1999;17:527-32.
27. Sokka T, Pincus T. Improved outcomes in consecutive patients with rheumatoid arthritis in 2000 compared to 1985, according to an identical cross-sectional quantitative standard protocol to evaluate rheumatoid arthritis (SPERA) [abstract], Arthritis Rheum 2002;49 Suppl 9:S242.
28. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
29. Da Silva E, Doran MF, Crowson CS, O'Fallon WM, Matteson EL. Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment. Arthritis Rheum 2003;49:216-20.
30. Callahan LF, Pincus T. Mortality in the rheumatic diseases. Arthritis Care Res 1995;8:229-41.
31. Boers M, Nieuwenhuyzen Kruseman AC, Eulderink F, Hermans J, Thompson J. The value of autopsy in internal medicine: a one-year prospective study of hospital deaths. Eur J Clin Invest 1988;18: 314-20.
32. Boers M, Croonen AM, Dijkmans BA, Breedveld FC, Eulderick F, Cats A, et al. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 1987;46:658-63.
33. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003;42:607-13.
34. Kroot EJ, van Gestel AM, Swinkels HL, Albers MM, van de Putte LB, van Riel PL. Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study. J Rheumatol 2001;28: 1511-7.
35. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994; 120:26-34.
36. Mitchell JM, Burkhauser RV, Pincus T. The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1988;31: 348-57.
37. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
38. Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries RR, Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis 1990;49:980-2.
39. Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:842-5.
40. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
41. Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002; 113:188-93.
42. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
43. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107: 1303-7.
44. Bacon PA, Townend JN. Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 2001;44:2707-10.
45. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
46. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
47. Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714-9.
48. Nielen MJ, van Halm VP, Nurmohamed MT, van Schaardenburg D, van de Stadt RJ, de Gast T, et al. Rheumatoid arthritis is preceded by a pre-clinical phase, characterised by increased C-reactive protein levels and a more atherogenic lipid profile [abstract]. Arthritis Rheum 2003;48:S344.
49. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
50. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
51. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-67.
52. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289: 2560-72.
53. Fontana SA, Baumann LC, Helberg C, Love RR. The delivery of preventive services in primary care practices according to chronic disease status. Am J Public Health 1997;87:1190-6.
54. Mendelssohn DC, Kua BT, Singer PA. Referral for dialysis in Ontario. Arch Intern Med 1995;155:2473-8.
55. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
56. Kremers HM, Bidaut-Russell M, Scott CG, Reinalda MS, Zinsmeister AR, Gabriel SE. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol 2003;30:1940-7.
57. Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, et al. Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ 1999;161:1403-8.
58. Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001;119:720-5.
59. Earle CC, Burstein HJ, Winer EP, Weeks JC. The quality of non-cancer care delivered to elderly breast cancer survivors [abstract]. Clin Oncol [article online]. 2001. URL http://www.asco. org/ac/1,1003,_12-002640-00_18-0010-00_19-00952,00.asp.